Portfolio Companies 2026 for Sofinnova Partners: investors, rounds, and co-investor patterns from StartupFundraising.com research, updated for 2026.
Sofinnova Partners accounts for 65 tracked companies with verified cap-table data, 65 of which disclose round sizes totalling $6.3B. The median disclosed raise is $80M, and the largest is CinCor Pharma at $400M, ahead of IO Biotech ($250M) and Amolyt Pharma ($210M).
The names that recur most often on these portfolio cap tables are Sofinnova Partners (65 companies), Forbion (6 companies), Novo Holdings (6 companies), M Ventures (5 companies), 5AM Ventures (4 companies), Eli Lilly and Company (4 companies). By latest disclosed round, the market skews Series A (20), Series B (17), Series C (9), Growth (6).
Companies tracked: 65
Disclosed funding total: $6.3B across 65 companies
Median disclosed raise: $80M
Largest raise: CinCor Pharma — $400M
Stage mix: Series A 20 · Series B 17 · Series C 9 · Growth 6
